在闭合的 mitra commissurotomy 之后进行 mitra 门置换
Circulation
|August 1, 1982
概括
关闭的 mitra commissurotomy (CMC) 显著改善了303名患者的 mitra 狭窄症症状和生存率. 对于一些人来说,需要进行中枢置换 (MVR),但也提供了显著的长期益处.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 膜心脏疾病 膜心脏疾病
背景情况:
- 获得的隔离性心肌狭窄症是一种显著的膜性心脏病.
- 关闭的 mitra commissurotomy (CMC) 是一个历史性的治疗选择.
- 长期结果和CMC后重新干预的预测因素需要评估.
研究的目的:
- 评估收购的隔离性额头管狭窄症的闭合额头管 commissurotomy (CMC) 的长期疗效和结果.
- 确定与随后的额头门置换 (MVR) 需要相关的因素.
- 评估之前接受CMC的患者MVR的结果.
主要方法:
- 在1954年至1980年间接受CMC治疗的303名患者的回顾性分析.
- 在CMC前后评估血液动力学参数 (心心梯度,面积指数) 和功能类.
- 精算生存分析和晚期MVR预测因素的识别.
主要成果:
- CMC显著降低了中枢梯度,增加了面积指数 (p < 0.001).
- 92%的患者在CMC后改善了功能类,5,10和15年生存率分别为95%,82%和70%.
- 18%的患者需要MVR,因为缩或残留狭窄;MVR也提供了显著的临床改善和生存益处.
结论:
- 关闭的 mitra commissurotomy (CMC) 提供了优秀的长期血液动力学和临床的好处,为选择的患者与 mitra 狭窄.
- 术前和术后早期的因素预测需要晚期的二手中置换 (MVR).
- 中心置换 (MVR) 对于经历CMC后症状恶化的患者来说是一个有效的选择.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


